Article Versions Notes

Dahl K, Johnström P, Tóth M, Bolin M, Varnäs K, Nakao R, Takano A, Khani Meynaq Y, Bayrakdarian M, Cselényi Z, et al. Radiolabeling and Preliminary In Vivo Evaluation of the Candidate CCR2 Targeting PET Radioligand [¹¹C]AZD2423. Pharmaceuticals. 2025; 18(2):135. https://doi.org/10.3390/ph18020135

Dahl, Kenneth, Peter Johnström, Miklós Tóth, Martin Bolin, Katarina Varnäs, Ryuji Nakao, Akihiro Takano, Yasir Khani Meynaq, Malken Bayrakdarian, Zsolt Cselényi, and et al. 2025. "Radiolabeling and Preliminary In Vivo Evaluation of the Candidate CCR2 Targeting PET Radioligand [¹¹C]AZD2423" Pharmaceuticals 18, no. 2: 135. https://doi.org/10.3390/ph18020135

Dahl, K., Johnström, P., Tóth, M., Bolin, M., Varnäs, K., Nakao, R., Takano, A., Khani Meynaq, Y., Bayrakdarian, M., Cselényi, Z., Halldin, C., Farde, L., & Schou, M. (2025). Radiolabeling and Preliminary In Vivo Evaluation of the Candidate CCR2 Targeting PET Radioligand [¹¹C]AZD2423. Pharmaceuticals, 18(2), 135. https://doi.org/10.3390/ph18020135